Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
 |
San Francisco Examiner - November 27, 2007
Stephen Hicks
Six years ago, there were 687 new cases. In 2006, they were 403 new cases. Each year since 2002, the number has declined.
Shannon Hader, senior deputy director of the city's HIV/AIDS Administration since October, didn't offer reasons for the peak in 2002.
"We have to focus on the solutions for now," Hader said. "The root cause 10 years ago is not the root cause today."
The report cited D.C. as having the highest number of new cases in a major U.S. city. D.C.'s new case figures are higher than Baltimore, New York, Philadelphia and Chicago.
In 2006, about 12,500 city residents were known to have HIV or AIDS, and D.C. children accounted for 9 percent of all U.S. pediatric cases, mainly from mother-to-child transmission, the statistics showed, even though medical treatment can prevent such transmissions.
The study, "District of Columbia HIV/AIDS Epidemiology Annual Report 2007," was organized by the D.C. HIV/AIDS Administration in coordination with George Washington University.
The report found heterosexual contact to be the leading mode of transmission in the city, at 37 percent of the newly reported infections. Nationally, homosexual contact leads in spreading the disease.
Blacks, who account for 57 percent of the city's population, make up 81 percent of all new HIV cases. Black women make up 58 percent of the District's female population but account for 90 percent of the new female HIV cases. Black men make up 52 percent of new HIV cases, the report stated.
Mayor Adrian Fenty put forth an action plan to counter the number of new cases. By 2009, he said he wants all hospital emergency rooms to offer testing; he wants to eliminate mother-to-child transmission and use $3.5 million in federal grants to target blacks in the District.
071127
SE071107
Copyright © 2007 - San Francisco Examiner. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Examiner, Permissions Desk, 110 Fifth Street, P.O. Box 7260, San Franciso, CA 94120.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .